Product Program year 2024 Source: CMS Open Payments

Evoke SCS

Device Spinal Cord Stimulation

Open in the dashboard

General payments

$2,318,376

7,179 payments

Research payments

$1,963,546

591 payments

Through program year 2024, $2,318,376 in general payments and $1,963,546 in research payments were reported against Evoke SCS (Spinal Cord Stimulation).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

8 rows
Year Kind Amount Payments
2024 Research $414,063 162
2023 General $1,728,431 6,032
2023 Research $593,260 186
2022 General $588,907 1,126
2022 Research $930,206 240
2021 Research $26,018 3
2020 General $620 14
2019 General $417 7

Breakdown

Who paid General payments · program years 2019–2023
  1. Saluda Medical Americas, Inc. $2,318,376 7,179 payments
Top recipients General payments · program year 2023
  1. Jason Pope Pain Medicine · Santa Rosa, CA $207,194 12% · 81 payments
  2. Nagy Mekhail Pain Medicine · Cleveland, OH $143,777 8% · 33 payments
  3. Erika Petersen Neurological Surgery · Little Rock, AR $77,401 4% · 44 payments
  4. Johnathan Goree Anesthesiology · Little Rock, AR $68,681 4% · 53 payments
  5. Dawood Sayed Pain Medicine · Kansas City, KS $66,470 4% · 28 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2023.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2023
  1. Pain Medicine Anesthesiology $738,901 44% · 366 practitioners
  2. Interventional Pain Medicine Pain Medicine $347,242 21% · 281 practitioners
  3. Anesthesiology $125,050 7% · 168 practitioners
  4. Neurological Surgery $124,869 7% · 66 practitioners
  5. Pain Medicine $106,952 6% · 97 practitioners

The top 5 of 64 specialties; each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2023
  1. California $374,224 22% · 176 recipients
  2. Ohio $165,960 10% · 52 recipients
  3. Arkansas $153,354 9% · 12 recipients
  4. North Carolina $146,681 8% · 130 recipients
  5. New Jersey $122,741 7% · 86 recipients

The top 5 of 47 states; each share is of general payments naming this product in 2023 where a state was reported.

The top 25 states, free in the app

7,179 general · 591 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record